The SysteMHC Atlas project
暂无分享,去创建一个
Roman A. Zubarev | Emanuel Schmid | Witold Wolski | Juan Antonio Vizcaíno | Eric W. Deutsch | Qi Wang | Stefan Stevanovic | Morten Nielsen | Alexey I. Nesvizhskii | Björn Peters | Miguel Marcilla | Alberto Paradela | Catherine E. Costello | Ralph Schlapbach | Anthony W. Purcell | Etienne Caron | Cecilia S. Lindestam Arlehamn | David S. Campbell | Robert L. Moritz | Hans-Georg Rammensee | Stefan H. E. Kaufmann | Heiko Schuster | Ruedi Aebersold | Albert J. R. Heck | Nicola Ternette | Tom H. M. Ottenhoff | Pierre Thibault | Claude Perreault | Arie Admon | Gustavo A. de Souza | Wenguang Shao | Patrick G. A. Pedrioli | Christian Scurtescu | Mathieu Courcelles | Daniel Kowalewski | Fabio Marino | Kerrie Vaughan | Alessandro Sette | Krista E. Meijgaarden | Natalie Nieuwenhuizen | John C. Castle | Anders Jimmy Ytterberg | Peter A. van Veelen | Cécile A. C. M. van Els | Ludvig M. Sollid | Michal Bassani-Sternberg | J. Castle | R. Aebersold | A. Nesvizhskii | H. Rammensee | S. Stevanović | R. Moritz | M. Nielsen | Bjoern Peters | A. Sette | E. Deutsch | A. Heck | D. Campbell | R. Schlapbach | E. Caron | C. Perreault | R. Zubarev | P. Thibault | J. Vizcaíno | W. Wolski | L. Sollid | A. Purcell | A. Admon | T. Ottenhoff | A. Ytterberg | Wenguang Shao | E. Schmid | M. Bassani-Sternberg | C. Costello | K. Vaughan | F. Marino | M. Marcilla | N. Ternette | N. Nieuwenhuizen | D. Kowalewski | C. L. Arlehamn | A. Paradela | K. Meijgaarden | P. Veelen | Qi Wang | C. Els | G. D. Souza | H. Schuster | M. Courcelles | S. Kaufmann | Christian Scurtescu | Miguel Marcilla | Natalie E. Nieuwenhuizen
[1] Maxim N. Artyomov,et al. Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens , 2014, Nature.
[2] J. Vizcaíno,et al. Exploring the potential of public proteomics data , 2015, Proteomics.
[3] Natalie I. Tasman,et al. iProphet: Multi-level Integrative Analysis of Shotgun Proteomic Data Improves Peptide and Protein Identification Rates and Error Estimates* , 2011, Molecular & Cellular Proteomics.
[4] Albert J R Heck,et al. Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD) , 2014, Proceedings of the National Academy of Sciences.
[5] Arie Admon,et al. The Human Immunopeptidome Project, a Suggestion for yet another Postgenome Next Big Thing , 2011, Molecular & Cellular Proteomics.
[6] J. Leunissen,et al. The Human Leukocyte Antigen–presented Ligandome of B Lymphocytes* , 2013, Molecular & Cellular Proteomics.
[7] Darren R. Flower,et al. Mycobacterium tuberculosis Peptides Presented by HLA-E Molecules Are Targets for Human CD8+ T-Cells with Cytotoxic as well as Regulatory Activity , 2010, PLoS pathogens.
[8] Sébastien Lemieux,et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation , 2011, Molecular systems biology.
[9] J. Neefjes,et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.
[10] Drew M. Pardoll,et al. The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.
[11] Etienne Caron,et al. Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry* , 2015, Molecular & Cellular Proteomics.
[12] Deborah Hix,et al. The immune epitope database (IEDB) 3.0 , 2014, Nucleic Acids Res..
[13] Catherine E Costello,et al. Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis. , 2017, Journal of proteome research.
[14] Ruedi Aebersold,et al. Highlights of the Biology and Disease-driven Human Proteome Project, 2015-2016. , 2016, Journal of proteome research.
[15] Morten Nielsen,et al. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions , 2011, Immunogenetics.
[16] S. Lemieux,et al. MHC class I-associated peptides derive from selective regions of the human genome. , 2016, The Journal of clinical investigation.
[17] E. Lundberg,et al. Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.
[18] D. Cole,et al. The ultimate mix and match: making sense of HLA alleles and peptide repertoires , 2015, Immunology and cell biology.
[19] Hans-Georg Rammensee,et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.
[20] Eric W. Deutsch,et al. Combining Results of Multiple Search Engines in Proteomics* , 2013, Molecular & Cellular Proteomics.
[21] D. Harlan,et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion , 2016, Science.
[22] Richard D Smith,et al. Recommendations for Mass Spectrometry Data Quality Metrics for Open Access Data (Corollary to the Amsterdam Principles)* , 2011, Molecular & Cellular Proteomics.
[23] George Coukos,et al. Mass spectrometry-based antigen discovery for cancer immunotherapy. , 2016, Current opinion in immunology.
[24] Nathan P Croft,et al. Quantifying epitope presentation using mass spectrometry. , 2015, Molecular immunology.
[25] Alessandro Sette,et al. An open-source computational and data resource to analyze digital maps of immunopeptidomes , 2015, eLife.
[26] Brendan MacLean,et al. CPTAC Assay Portal: a repository of targeted proteomic assays , 2014, Nature Methods.
[27] P. Kloetzel,et al. A large fraction of HLA class I ligands are proteasome-generated spliced peptides , 2016, Science.
[28] Jennifer G. Abelin,et al. Mass Spectrometry Profiling of HLA‐Associated Peptidomes in Mono‐allelic Cells Enables More Accurate Epitope Prediction , 2017, Immunity.
[29] Matthias Mann,et al. Origins of mass spectrometry-based proteomics , 2016, Nature Reviews Molecular Cell Biology.
[30] Morten Nielsen,et al. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires , 2014, Immunogenetics.
[31] Alessandro Sette,et al. Deciphering the human antigenome , 2016, Expert review of vaccines.
[32] Ash A. Alizadeh,et al. Antigen Presentation Profiling Reveals Recognition of Lymphoma Immunoglobulin Neoantigens , 2017, Nature.
[33] Hans-Georg Rammensee,et al. HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL) , 2014, Proceedings of the National Academy of Sciences.
[34] Ben C. Collins,et al. OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data , 2014, Nature Biotechnology.
[35] Sorin Istrail,et al. Comparative immunopeptidomics of humans and their pathogens. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] Ruedi Aebersold,et al. A first dataset toward a standardized community-driven global mapping of the human immunopeptidome , 2016, Data in brief.
[37] John Chilton,et al. Using iRT, a normalized retention time for more targeted measurement of peptides , 2012, Proteomics.
[38] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[39] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[40] Jennifer G. Abelin,et al. MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia , 2013, Science Translational Medicine.
[41] Ole Lund,et al. Genome-Based In Silico Identification of New Mycobacterium tuberculosis Antigens Activating Polyfunctional CD8+ T Cells in Human Tuberculosis , 2011, The Journal of Immunology.
[42] Albert J R Heck,et al. Arginine (Di)methylated Human Leukocyte Antigen Class I Peptides Are Favorably Presented by HLA-B*07. , 2017, Journal of proteome research.
[43] Bjoern Peters,et al. Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset , 2013, PLoS pathogens.
[44] M. Mann,et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry , 2016, Nature Communications.
[45] Chris Sander,et al. Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome , 2016, Cell.
[46] Shabaz Mohammed,et al. Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity* , 2016, Molecular & Cellular Proteomics.
[47] K. Rock,et al. Present Yourself! By MHC Class I and MHC Class II Molecules. , 2016, Trends in immunology.
[48] Ilka Hoof,et al. Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome , 2015, PloS one.
[49] David Gfeller,et al. Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide–HLA Interactions , 2016, The Journal of Immunology.
[50] Eric W. Deutsch,et al. The PeptideAtlas project , 2005, Nucleic Acids Res..
[51] Brian A. Nosek,et al. How open science helps researchers succeed , 2016, eLife.
[52] R. Henderson,et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.
[53] Lennart Martens,et al. A Golden Age for Working with Public Proteomics Data , 2017, Trends in biochemical sciences.
[54] Gary D Bader,et al. The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community. , 2013, Journal of proteome research.
[55] Anne M Evans,et al. Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy , 2006, Proceedings of the National Academy of Sciences.
[56] Ruedi Aebersold,et al. Building consensus spectral libraries for peptide identification in proteomics , 2008, Nature Methods.